Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Seattle Genetics Inc (SGEN)

64.265 +1.375 (+2.186%)

10/17/2017  2:44pm

Open:

62.790

Pre. Close:

62.890

High:

64.430

Low:

62.590

Volume:

703,738

Market Cap:

9.19B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

64.56 - 65.31

65.31 - 65.98

Low:

59.98 - 60.77

60.77 - 61.47

Close:

61.64 - 62.99

62.99 - 64.18

Technical analysis  (as of: 2017-10-17 2:36:27 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 75.25     One year: 87.90

Support:

Support1: 56.24    Support2: 51.17

Resistance:

Resistance1: 64.43    Resistance2: 75.25

Pivot:

58.75

Moving Averages:

MA(5): 62.69     MA(20): 57.22

MA(100): 54.90     MA(250): 59.65

MACD:

MACD(12,26): 2.84     Signal(12,26,9): 2.18

%K %D:

%K(14,3): 95.53     %D(3): 91.95

RSI:

RSI(14): 80.84

52-Week:

High: 75.360  Low: 45.310  Change(%): 25.5

Average Vol(K):

3-Month: 97291  10-Days 89085

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SGEN has closed below upper band by 7.1%. Bollinger Bands are 59% wider than normal. The large width of the bands suggest high volatility as compared to SGEN's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

Wed, 11 Oct 2017 21:00:00 GMT
Why Snap, Seattle Genetics, and Pretium Resources Jumped Today

Tue, 03 Oct 2017 14:53:26 GMT
Seattle Genetics' Adcetris Gets Breakthrough Therapy Status

Mon, 02 Oct 2017 21:30:05 GMT
Seattle Genetics Inc. (SGEN) Moves Higher on Volume Spike for October 02

Tue, 17 Oct 2017 16:52:30 GMT
Seattle Genetics' (SGEN) “Hold” Rating Reaffirmed at SunTrust Banks, Inc.

Mon, 02 Oct 2017 11:15:24 GMT
Seattle Genetics' ADCETRIS Gets FDA Breakthrough Therapy Designation

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

95.82

% Held by Insiders

1.20

% Held by Institutions

99.25

Shares Short (K)

10980

Shares Short Prior Month (K)

10550

Stock Financials

EPS

-1.430

EPS Est. Current Year

-1.690

EPS Est. Next Year

-1.220

EPS Est. Next Quarter

-0.450

Forward EPS

-1.130

Book Value (p.s.)

4.010

PEG Ratio

-0.08

Profit Margin

-47.38

Operating Margin

-48.22

Return on Assets (ttm)

-15.9

Return on Equity (ttm)

-32.7

Qtrly Rev. Growth

13.4

Gross Profit (p.s.)

2.628

Sales Per Share

EBITDA (p.s.)

-1.309

Qtrly Earnings Growth

Operating Cash Flow (M)

-154.92

Levered Free Cash Flow (M)

-116.10

FoxReading.com

Valuation

P/E

-44.99

P/E Growth Ratio

0.02

P/BV

16.04

P/S

3046965248.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.